Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Feb 26, 2016

30071_dirs_2016-02-26_e5311d1f-518d-441c-9cd8-cdd00893b10e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-02-23

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-23 ResMed Common Stock M 3000 $20.355 Acquired 79300.126 Direct
2016-02-23 ResMed Common Stock F 1054 $57.94 Disposed 78246.126 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-23 ResMed Common Stock Options $20.355 M 3000 Disposed 2016-02-23 ResMed Commmon Stock (3000) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.

F2: Disposition to issuer for payment of cost of equity security by netting of shares from expiring stock options granted on 2/23/2016.